Skip to main content
Medtronic10-Q: Restructuring

Medtronic reorganizes Cardiovascular Portfolio divisions and transitions Diabetes Business out of reportable segments

Source: Autobound Signal API · 99 signals tracked for Medtronic · updated

Get Medtronic's live signals in Claude or ChatGPT, or by API

AskWhat changed at Medtronic this week? Use Autobound signals for medtronic.com.

What happened

Starting in Q1 FY2027, Medtronic transitioned its Cardiovascular Portfolio into four new divisions (EPT, ICT, CVS, and PVH) and removed the Diabetes Business from reportable segments ahead of a planned separation. Operational and reporting overhauls of this scale often trigger evaluations of business applications, integration software, and workflow tools.

Source

SEC EDGARSep 3, 2026

Quarterly report (Form 10-Q)

Medtronic 10-Q for Quarter ended Jul 31, 2026

Filing excerpt

Starting in the first quarter of fiscal year 2027, the Cardiovascular Portfolio divisions transitioned from Cardiac Rhythm & Heart Failure, Structural Heart & Aortic, and Coronary & Peripheral Vascular to Electrophysiology Therapies (EPT), Interventional Cardiology Therapies (ICT), CardioVascular Surgery (CVS), and Peripheral Vascular Health (PVH).

sec.gov/Archives/edgar/data/1613103/000162828026060473/mdt-20260731.htmRead the full source

Other signals in this filing (3)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Restructuring

What this signalsFilings often name leadership changes, deals and spending plans.

Period
Quarter ended Jul 31, 2026
Fiscal year end
07/31
Filed
Sep 3, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Details

CIK
1613103
Accession number
0001628280-26-060473
Timeframe
Current quarter
Quarter
Q1
Filing year
2026
Fiscal year
2027
Period end date
Jul 31, 2026
Why it matters
Change management needs
Signal category
Workforce

Extraction

Confidence
High
Relevance
80%
Sentiment
Neutral
Detected
Nov 9, 2026
signal_type
sec-10q
signal_subtype
restructuring

Use this data

Get every 10-Q signal for Medtronic and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Medtronic this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/ca6ab93e-65d7-4746-af5f-0a2e6a34e7d8 returns this record as JSON. POST /v1/companies/enrich returns every signal for medtronic.com.

{
  "signal_id": "ca6ab93e-65d7-4746-af5f-0a2e6a34e7d8",
  "signal_type": "sec-10q",
  "signal_subtype": "restructuring",
  "detected_at": "2026-11-09T06:34:41.429+00:00",
  "company": {
    "name": "Medtronic",
    "domain": "medtronic.com"
  },
  "data": {
    "detail": "Starting in Q1 FY2027, Medtronic transitioned its Cardiovascular Portfolio into four new divisions (EPT, ICT, CVS, and PVH) and removed the Diabetes Business from reportable segments ahead of a planned separation. Operational and reporting overhauls of this scale often trigger evaluations of business applications, integration software, and workflow tools.",
    "metrics": {
      "timeframe": "current_quarter"
    },
    "quarter": "Q1",
    "summary": "Medtronic reorganizes Cardiovascular Portfolio divisions and transitions Diabetes Business out of reportable segments",
    "excerpts": "Starting in the first quarter of fiscal year 2027, the Cardiovascular Portfolio divisions transitioned from Cardiac Rhythm & Heart Failure, Structural Heart & Aortic, and Coronary & Peripheral Vascular to Electrophysiology Therapies (EPT), Interventional Cardiology Therapies (ICT), CardioVascular Surgery (CVS), and Peripheral Vascular Health (PVH).",
    "relevance": 0.8,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1613103/000162828026060473/mdt-20260731.htm",
    "filing_date": "2026-09-03",
    "filing_year": 2026,
    "fiscal_year": 2027,
    "fiscal_year_end": "07/31",
    "period_end_date": "2026-07-31",
    "sales_relevance": "Change management needs",
    "signal_category": "workforce"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.